PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long-term users of ecstasy risk structural brain damage

Preliminary evidence of hippocampal damage in chronic users of ecstasy

2011-04-07
(Press-News.org) Long term users of the popular recreational drug ecstasy (MDMA) risk structural brain damage, suggests preliminary research published online in the Journal of Neurology, Neurosurgery and Psychiatry.

Other research has suggested that people who use ecstasy develop significant memory problems, so the Dutch researchers wanted to find out if there was any clinical evidence of structural changes in the brain to back this up.

They focused on the hippocampus, which is the area of the brain responsible for long term memory.

They measured the volume of the hippocampus using MRI scans in 10 young men in their mid 20s who were long term users of ecstasy and seven of their healthy peers in their early 20s with no history of ecstasy use.

Although the ecstasy group had used more amphetamine and cocaine than their peers, both sets of young men had used similar amounts of recreational drugs, bar ecstasy, and drank alcohol regularly.

The ecstasy group had not been using on average for more than two months before the start of the study, but had taken an average of 281 ecstasy tablets over the preceding six and a half years.

The MRI scans showed that hippocampal volume in this group was 10.5% smaller than that of their peers, and the overall proportion of grey matter was on average 4.6% lower, after adjusting for total brain volume.

This indicates that the effects of ecstasy may not be restricted to the hippocampus alone, say the authors

"Taken together, these data provide preliminary evidence suggesting that ecstasy users may be prone to incurring hippocampal damage, following chronic use of this drug," they write.

They add that their findings echo those of other researchers who have reported acute swelling and subsequent atrophy of hippocampal tissue in long term ecstasy users.

And they point out: "Hippocampal atrophy is a hallmark for diseases of progressive cognitive impairment in older patients, such as Alzheimer's disease.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Four Out of Five Community Hospitals Pin HITECH Hopes on Current Electronic Medical Records

2011-04-07
Electronic medical records (EMRs) are garnering deeper use in the community hospital scene, and nearly all have been certified HITECH-ready by an official certification body. Nevertheless, a fifth of these hospitals plan to switch EMR products within the next couple of years -- even this close to meaningful use (MU) deadlines -- according to a new report by KLAS. For the new report, "Community Hospital EMRs Maturing for Meaningful Use," KLAS interviewed more than 500 healthcare professionals about their experience with various EMR systems. Of respondents, 80 percent ...

Regular retail therapy prolongs life

2011-04-07
A spot of regular retail therapy really does seem to help people live longer, suggests research published online in the Journal of Epidemiology and Community Health. And it seems to benefit older men the most, the findings show. The authors base their findings on almost 1,850 elderly (65+) Taiwanese people who were living independently at home, and included in the nationally representative Elderly Nutrition and Health Survey in Taiwan (NAHSIT Elderly), carried out in 1999-2000. Participants were asked how often they went shopping, with options ranging from "never" ...

Epileptic seizures linked to significant risk of subsequent brain tumor

2011-04-07
Epileptic seizures can precede the development of a subsequent brain tumour by many years, suggests research published online in the Journal of Neurology, Neurosurgery and Psychiatry. The risk seems to be greatest among those aged between 15 and 44 when first admitted to hospital for an epileptic seizure, the findings show. The researchers base their findings on first time admissions for epilepsy from the Oxford Record Linkage Study (ORLS) for 1963 to 1998, and national Hospital Episode Statistics (HES) data for England for 1999 to 2005. These data were then linked ...

FinancialSpreads.com Adds Differential Spread Betting Markets

FinancialSpreads.com Adds Differential Spread Betting Markets
2011-04-07
Financial Spreads, the UK-based spread betting company, has introduced another set of improvements for their clients. This year Financial Spreads have already tightened their spreads on a number of popular markets in order to lower the cost of trading for clients. They have also introduced Guaranteed Stops in order to help clients with their risk management. The spread betting company has now introduced 'differential markets'. Financial Spreads Spokesperson Adam Jepsen says that introducing differential markets not only offers account holders more choice, but better ...

Antibiotic-resistant bacteria in Indian public water supply

2011-04-07
Disease-causing bacteria carrying the new genetic resistance to antibiotics, NDM-1, have been discovered in New Delhi's drinking water supply. A Cardiff University-led team found new strains of resistant bacteria in the Indian capital, including species which cause cholera and dysentery. The findings are the first evidence of the environmental spread of NDM-1, which had previously only been found in hospitals. The scientists are calling for urgent action by health authorities worldwide to tackle the new strains and prevent their global spread. The Cardiff scientists ...

Researchers find link between common dietary fat, intestinal microbes and heart disease

2011-04-07
A new pathway has been discovered that links a common dietary lipid and intestinal microflora with an increased risk of heart disease, according to a Cleveland Clinic study published in the latest issue of Nature. The study shows that people who eat a diet containing a common nutrient found in animal products (such as eggs, liver and other meats, cheese and other diary products, fish, shellfish) are not predisposed to cardiovascular disease solely on their genetic make-up, but rather, how the micro-organisms that live in our digestive tracts metabolize a specific lipid ...

Researchers ID microbe responsible for methane from landfills

2011-04-07
Researchers have long known that landfills produce methane, but had a hard time figuring out why – since landfills do not start out as a friendly environment for the organisms that produce methane. New research from North Carolina State University shows that one species of microbe is paving the way for other methane producers. Specifically, the researchers found that an anaerobic bacterium called Methanosarcina barkeri appears to be the key microbe. "Landfills receive a wide variety of solid waste, and that waste generally starts out with a fairly low pH level," says ...

Neural guidance gene regulates liver development

2011-04-07
Scientists of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch (Germany) have demonstrated for the first time that a gene regulating neuronal cell migration during embryogenesis also plays a role in the development of the liver. Using zebrafish as a model organism, Dr. Christian Klein and Professor Ferdinand le Noble showed that the gene navigator-3 (abbreviated nav3a) regulates liver organogenesis. If nav3a is missing, the liver cannot develop (Development 2011, doi:10.1242/dev.056861)*. "Moreover, first evidence indicates," Dr. Klein said, "that the expression ...

Most recent mammography recommendations confuse public

2011-04-07
San Diego, CA, April 6, 2011 – When the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts in primary care and prevention, released its recommendations on mammography screenings for US women on November 16, 2009, there was immediate and considerable controversy. In a study published in the May 2011 issue of the American Journal of Preventive Medicine, investigators report that these new recommendations confused women (30.0%) more than they helped them understand when to get a mammogram (6.2%). Confusion was greatest among women aged 40-49 years ...

New drug shrinks cancer in animals, U-M study shows

2011-04-07
ANN ARBOR, Mich. — A study led by researchers at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects. The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppressor function. This allows the tumor to grow unchecked. The new ...

LAST 30 PRESS RELEASES:

Artificial intelligence enhances monitoring of threatened marbled murrelet

The solution to kidney bleeding and recovery lies within a hemostasis sponge, using the inherent capabilities of the kidneys

Sylvester Cancer adding cellular therapy to its arsenal against metastatic melanoma

Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

Medical school scientist creates therapy to kill hypervirulent bacteria

New study supports psilocybin’s potential as an antidepressant

The Lancet Public Health: Global study reveals stark differences between females and males in major causes of disease burden, underscoring the need for gender-responsive approaches to health

Revealed: face of 75,000-year-old female Neanderthal from cave where species buried their dead

Hepatitis B is globally underassessed and undertreated, especially among women and Asian minorities in the West

Efficient stochastic parallel gradient descent training for on-chip optical processors

Liquid crystal-integrated metasurfaces for an active photonic platform

Unraveling the efficiency losses and improving methods in quantum dot-based infrared up-conversion photodetectors

A novel deep proteomic approach unveils molecular signatures affected by aging and resistance training

High-intensity spatial-mode steerable frequency up-converter toward on-chip integration

Study indicates that cancer patients gain important benefits from genome-matched treatments

Gift to UCR clinic aims to assist local unhoused population

Research breakthrough on birth defect affecting brain size

Researchers offer US roadmap to close the carbon cycle

Precipitation may brighten Colorado River’s future

Identifying risks of human flea infestations in plague-endemic areas of Madagascar

Archaea can be picky parasites

EPA underestimates methane emissions from landfills, urban areas

Feathers, cognition and global consumerism in colonial Amazonia

Satellite images of plants’ fluorescence can predict crop yields

Machine learning tool identifies rare, undiagnosed immune disorders through patients’ electronic health records

MD Anderson researcher Sharon Dent elected to prestigious National Academy of Sciences

Nonmotor seizures may be missed in children, teens

Emergency departments frequently miss signs of epilepsy in children

Unraveling the roles of non-coding DNA explains childhood cancer’s resistance to chemotherapy

Marshall University announces new clinical trial studying the effect of ACL reconstruction on return to play in sports

[Press-News.org] Long-term users of ecstasy risk structural brain damage
Preliminary evidence of hippocampal damage in chronic users of ecstasy